What is hematocrit?
Hematocrit is the percentage of your total blood volume composed of red blood cells. A hematocrit of 45% means that 45% of your blood is red blood cells and 55% is plasma and other components. Normal hematocrit for adult men ranges from 38.3% to 48.6%, though lab reference ranges vary slightly. Hemoglobin — the oxygen-carrying protein inside red blood cells — is measured alongside hematocrit and tracks proportionally.
Red blood cells carry oxygen from the lungs to tissues throughout the body. More red blood cells means more oxygen delivery capacity, which is why elevated hematocrit can initially feel like increased energy and endurance. However, past a certain point, the increase in blood viscosity outweighs the oxygen-carrying benefit and creates cardiovascular risk.
Why does TRT raise hematocrit?
Testosterone is a potent stimulator of erythropoiesis — the production of red blood cells in bone marrow. It works through multiple mechanisms: direct stimulation of erythroid progenitor cells, increased erythropoietin (EPO) production by the kidneys, and enhanced iron absorption from the gut. This effect is dose-dependent, meaning higher testosterone levels produce greater red blood cell stimulation.
A 2017 meta-analysis published in The Journal of Clinical Endocrinology & Metabolismconfirmed that testosterone therapy increases hematocrit by an average of 3-5% over 6-12 months. The incidence of polycythemia (hematocrit exceeding 54%) was approximately 12% in men using injectable testosterone. Transdermal formulations caused less hematocrit elevation, likely due to lower peak testosterone levels and more stable daily dosing.
Several factors predict how much your hematocrit will rise: your baseline hematocrit before starting TRT, your dose and delivery method, altitude (men living above 4,000 feet start with higher baselines), smoking status, sleep apnea (which independently elevates erythropoietin), and individual genetic variation in erythropoietic sensitivity.
What are the risk thresholds?
The Endocrine Society's 2018 clinical practice guidelines set 54% as the hematocrit threshold for intervention during TRT. At this level, blood viscosity is sufficiently elevated to increase the risk of thromboembolic events — blood clots that can cause stroke, deep vein thrombosis (DVT), pulmonary embolism, or myocardial infarction.
| Hematocrit Level | Risk Category | Recommended Action |
|---|---|---|
| <48% | Normal | Routine monitoring per schedule |
| 48-50% | Upper normal | Monitor trend; ensure adequate hydration |
| 50-54% | Elevated | Increase monitoring frequency; consider dose reduction or blood donation |
| >54% | High risk | Reduce dose, donate blood/phlebotomy, or discontinue TRT; recheck in 4-6 weeks |
The 54% threshold is a guideline, not a bright line. Risk increases progressively as hematocrit rises above 50%. A man at 53% with a rapidly climbing trend and additional cardiovascular risk factors (smoking, hypertension, sedentary lifestyle) may warrant earlier intervention than someone at 53% who has been stable at that level for a year with no other risk factors.
Important: Dehydration artificially elevates hematocrit by reducing plasma volume. If your hematocrit reads high, ensure you were well-hydrated at the time of the draw. A repeat test after proper hydration may show a lower, more accurate value. Never skip a recheck by assuming dehydration was the cause.
What does high hematocrit feel like?
Mildly elevated hematocrit (48-52%) often produces no noticeable symptoms. Some men report subtle signs such as facial flushing or redness, headaches (particularly upon waking), shortness of breath during exertion, and a sensation of heaviness or fullness in the head. These symptoms are nonspecific and easily attributed to other causes.
Significantly elevated hematocrit above 54% can cause more pronounced symptoms: persistent headaches, visual disturbances, dizziness, chest tightness, and numbness or tingling in the extremities. These symptoms reflect increased blood viscosity and impaired microcirculation. If you experience sudden, severe headache, chest pain, difficulty breathing, or neurological symptoms (vision changes, weakness on one side, slurred speech), seek emergency medical attention — these can indicate an acute thromboembolic event.
How do you lower hematocrit on TRT?
Managing hematocrit on TRT involves a tiered approach. Lifestyle measures and protocol adjustments come first; therapeutic phlebotomy provides faster correction when needed; and dose reduction or delivery method changes address the root stimulus.
Reduce dose or change delivery method
Since testosterone stimulates erythropoiesis in a dose-dependent fashion, reducing your dose will slow red blood cell production. A reduction from 200 mg/week to 150 mg/week, for instance, can meaningfully lower hematocrit while potentially maintaining adequate testosterone levels. Switching from intramuscular injections to transdermal testosterone (gels or creams) reduces peak testosterone levels and tends to produce less hematocrit elevation. More frequent, smaller injections (every other day or three times weekly) also blunt peaks and may help.
Grapefruit and naringin
Naringin, a flavonoid found in grapefruit, has shown preliminary evidence of reducing hematocrit in some men. A small number of TRT-focused clinicians recommend grapefruit juice or naringin supplements, though robust clinical trial data is lacking. This is a low-risk intervention but should not replace phlebotomy or dose adjustment when hematocrit is significantly elevated. Note: grapefruit interacts with certain medications — check with your provider.
How does therapeutic phlebotomy and blood donation work?
Whole blood donation is the fastest way to lower hematocrit. Removing approximately 450-500 mL of whole blood (one standard unit) reduces hematocrit by roughly 3-4 percentage points. The American Red Cross allows donations every 56 days, and you can donate at most blood banks without disclosing that you are on TRT (though you should answer screening questions honestly).
If you need more frequent blood removal than the Red Cross schedule allows, your provider can order therapeutic phlebotomy at a medical facility or infusion center. This is the same procedure as blood donation but performed under medical supervision, typically on a schedule tailored to your hematocrit levels. The blood removed is usually discarded rather than donated.
One caveat about frequent phlebotomy: it depletes iron stores over time. Regular blood removal without iron monitoring can lead to iron deficiency anemia — a situation where hematocrit is controlled but you feel fatigued because your remaining red blood cells lack adequate hemoglobin. If you donate blood more than 3-4 times per year, ask your provider to check ferritin periodically.
How do hydration and lifestyle affect hematocrit?
Hematocrit is a ratio — red blood cells relative to total blood volume. Dehydration reduces plasma volume, artificially concentrating red blood cells and inflating the hematocrit reading. Chronic mild dehydration is common and can make hematocrit appear 2-3 percentage points higher than your true, hydrated baseline.
Practical hydration targets for men on TRT: consume at least 80-100 oz of water daily, more if you exercise heavily, live in a hot climate, or consume caffeine and alcohol (both are diuretics). Hydrate well the day before and morning of your blood draw to ensure accurate results.
Sleep apnea independently elevates hematocrit by triggering hypoxia-driven EPO production during the night. If you snore heavily, wake with headaches, or have persistent daytime sleepiness, a sleep study is worth pursuing — treating sleep apnea with CPAP can reduce hematocrit independent of any TRT adjustments.
Smoking also elevates hematocrit through chronic carbon monoxide exposure, which stimulates compensatory red blood cell production. Quitting smoking can reduce hematocrit by 2-4 percentage points.
How often should you check hematocrit on TRT?
Hematocrit should be checked at every TRT lab draw — it is the one marker that warrants consistent monitoring regardless of how stable your protocol is. The Endocrine Society recommends checking at baseline, 3-6 months after starting TRT or changing a dose, and at least annually thereafter.
If your hematocrit is trending upward — even within the normal range — increase monitoring frequency to every 3 months until the trend stabilizes. If you have had a phlebotomy or made a protocol adjustment to address elevated hematocrit, recheck 4-6 weeks afterward to confirm the intervention was effective.
For the full monitoring timeline across all TRT markers, see our blood work frequency guide. For a broader view of every lab marker you should be tracking, return to the complete TRT blood work guide.
When is hematocrit too high to continue TRT?
Discontinuing TRT due to hematocrit is rare but occasionally necessary. If hematocrit remains above 54% despite dose reduction, delivery method changes, and regular phlebotomy, the risk-benefit calculus shifts. Your provider may recommend a temporary pause to allow hematocrit to normalize, followed by reintroduction at a lower dose or with a different delivery method.
Men with underlying conditions that predispose to polycythemia — including polycythemia vera, chronic obstructive pulmonary disease (COPD), or untreated severe sleep apnea — face higher baseline risk and require closer monitoring and lower intervention thresholds.
Key takeaway: Hematocrit elevation is manageable in the vast majority of TRT patients. The combination of regular monitoring, adequate hydration, strategic blood donation, and protocol flexibility keeps this side effect well-controlled. The key is not to ignore it — check it at every blood draw and act on trends before they become problems.
Frequently Asked Questions
How much does TRT raise hematocrit?
TRT typically raises hematocrit by 3-5 percentage points over the first 6-12 months. A man starting at 44% might reach 47-49%. The degree of increase depends on dose, delivery method (injectables raise it more than topicals), individual genetics, and altitude. Approximately 12% of men on injectable TRT develop hematocrit above 54%.
At what hematocrit level should I be concerned?
The Endocrine Society recommends taking action if hematocrit exceeds 54%. However, a rapidly rising hematocrit — even below 54% — warrants attention. If your hematocrit jumps from 44% to 52% in three months, your provider should investigate and potentially adjust your protocol before it crosses the threshold.
Can I donate blood to lower hematocrit on TRT?
Yes. Whole blood donation removes red blood cells and is an effective way to lower hematocrit. The American Red Cross allows donation every 56 days. A single donation typically reduces hematocrit by 3-4 percentage points. If you need more frequent removal, your provider can order therapeutic phlebotomy through a medical facility.
Does lowering testosterone dose help hematocrit?
Yes. Since testosterone stimulates red blood cell production in a dose-dependent manner, reducing your dose will slow erythropoiesis and lower hematocrit over time. Switching from injectable to transdermal testosterone may also help, since injections cause higher peaks and more erythropoietic stimulation.
Is high hematocrit on TRT dangerous?
Elevated hematocrit increases blood viscosity, which raises the risk of thromboembolic events including stroke, deep vein thrombosis, and pulmonary embolism. The risk increases progressively above 50% and becomes clinically significant above 54%. Regular monitoring and timely intervention keep this risk manageable for most men on TRT.